The FcγRIIa polymorphism in Turkish children with asthma bronchial and allergic rhinitis

Clinical Biochemistry

Volumn 40, Issue 5-6, 2007, Pages 392-396

  Gulen, Figen ^a   Tanac, Remziye ^a   Altinoz, Serdar ^a   Berdeli, Afig ^b   Zeyrek, Dost ^a   Koksoy, Huseyin ^a   Demir, Esen ^a  

^a EGE UNIVERSITY   (Turkey)

^b Aegean University School of Medicine   (Turkey)

Author keywords

Allergic rhinitis; Asthma bronchial; Children; Fc RIIa gene; Polymorphism

Indexed keywords

CARRIER PROTEIN; FC GAMMA RECEPTOR 2A; UNCLASSIFIED DRUG; FC GAMMA RECEPTOR IIA; FC RECEPTOR; LEUKOCYTE ANTIGEN;

ADOLESCENT; ALLELE; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CHEMICAL ANALYSIS; CHILD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FC GAMMA RECEPTOR 2A GENE; FEMALE; GENE; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK; TURKEY (REPUBLIC); ASTHMA; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; PATHOLOGY; PERENNIAL RHINITIS;

ADOLESCENT; ANTIGENS, CD; ASTHMA; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; RECEPTORS, IGG; RHINITIS, ALLERGIC, PERENNIAL; TURKEY;

EID: 33847185838     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.11.014     Document Type: Article

References (30)

1. Holgate St. Genetic and environmental interaction in allergy and asthma. J. Allergy Clin. Immunol. 104 (1999) 1139-1146
2. Vercelli D. Genetic polymorphism in allergy and asthma. Curr. Opin. Immunol. 15 (2003) 609-613
3. Van de Winkel J.G.J., and Capel P.J.A. Human IgG Fc receptor heterogenity: molecular aspects and clinical implications. Immunol. Today 14 (1993) 215-220
4. van Sorge N.M., van der Pol W.L., and van de Winkel J.G. Fcgamma R polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 61 (2003) 189-202
5. Parren P.W.H.I., Warmerdam P.A.M., Boeije L.C.M., et al. On the interaction of IgG subclasses with the low affinity FcγRIIa (CD32) on human monocytes, neutrophils, and platelets: analysis of a functional polymorphism to human IgG2. J. Clin. Invest. 90 (1992) 1537-1546
6. Warmerdam P.A.M., Van de Winkel J.G.J., Gosselin E.J., and Capel P.J.A. Molecular basis for a polymorphism of human Fcγ receptor II (CD32). J. Exp. Med. 172 (1990) 19-25
7. Sanders L.A., Feldman R.G., Voorhorst-Ogink M.M., et al. Human immunoglobulin G (IgG) Fc receptor IIa (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils. Infect. Immun. 63 (1995) 73-81
8. Lehrnbecher T., Foster C.B., Zhu S., et al. Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood 94 (1999) 4220-4232
9. Sanders L.A.M., Van de Winkel J.G.J., Rijkers G.T., et al. FcÁ receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J. Infect. Dis. 170 (1994) 854-861
10. Carlsson L.E., Santoso S., Baurichter G., et al. Heparin induced thrombocytopenia: new insights into the impact of the FcÁRIIa R-H131 polymorphism. Blood 92 (1998) 1526-1531
11. Burgess J.K., Lindeman R., Chesterman C.N., and Chong B.H. Single amino acid mutation of FcÁ receptor is associated with the development of heparin-induced thrombocytopenia. Br. J. Haematol. 91 (1995) 761-766
12. Salmon J.E., Millard S., Schachter L.A., et al. FcÁRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J. Clin. Invest. 97 (1996) 1348-1354
13. Ando A., Martin T.R., and Galli S.J. Effect of chronic treatment with the c-kit ligand, stem cell factor, on immunoglobulin E-dependent anaphylaxis in mice. J. Clin. Invest. 92 (1993) 1639-1649
14. Martin T.R., Galli S.J., Katona I.M., and Drazen J.M. Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice. J. Clin. Invest. 83 (1989) 1375-1383
15. Miyajima I., Dombrowicz D., and Martin T.R. Systemic anaphylaxis in the mouse can be mediated largely through IgG and FcgRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active IgE- or IgG1-dependent passive anaphylaxis. J. Clin. Invest. 99 (1997) 915-925
16. Dombrowicz D., Flamand V., Miyajima I., et al. Absence of Fcepsilon RI alpha chain results in upregulation of FcgRIII-dependent mast cell degranulation, and anaphylaxis. Evidence of competition between Fc epsilon RI and FcgRIII for limiting amounts of FcR B and γ chain. J. Clin. Invest. 99 (1997) 901-914
17. Global initiative for asthma (GINA). Global strategy for asthma management and prevention. NHLBI/WHO workshop report. National Institute of Health. National Heart, Lung and Blood Institute. Publication No: 02-3659, Revised 2002.
18. Wilson A., Dempsey O.J., Sims E.J., et al. Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak unspiratory flow. Clin. Exp. Allergy 30 (2000) 833-838
19. Meltzer E.O., Malmstrom K., Lu S., et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: clinical trial. J. Allergy Clin. Immunol. 105 (2000) 917-922
20. Dreborg S., and Frew A. Allergen standardization and skin tests. EAACI Position Paper. Allergy 48 Suppl. 14 (1993) 49-82
21. Koene H.R., Kleijer M., Swaak A.J., et al. The FcgammaRIIIa: 158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum. 41 (1998) 1813-1818
22. Rascu A., Repp R., Westerdaal N.A., Kalden J.R., and van de Winkel J.G. Clinical relevance of Fc gamma receptor polymorphisms. Ann. N. Y. Acad Sci. 815 (1997) 282-295
23. Ozturk C., Aksu G., Berdeli A., and Kutukculer N. Fc gamma RIIa, IIIa and IIIb polymorphisms in Turkish children susceptible to recurrent infectious diseases. Clin. Exp. Med. 6 (2006) 27-32
24. Karassa F.B., Trikalinos T.A., and Ioannidis J.P. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum. 46 (2002) 1563-1572
25. Bredius R.G., Derkx B.H., Fijen C.A., et al. Fc gamma receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J. Infect. Dis. 170 (1994) 848-853
26. Platonov A.E., Shipulin G.A., Vershinina I.V., et al. Association of human Fc gamma RIIa (CD32) polymorphism with susceptibility to and severity of meningococcal disease. Clin. Infect. Dis. 27 (1998) 746-750
27. Berdeli A., Celik H., Ozyurek R., and Aydin H. Involvement of immunoglobulin FcγRIIA and FcγRIIIB gene polymorphisms in susceptibility to rheumatic fever. Clin. Biochem. 37 (2004) 925-929
28. Takizawa F., Adamczewski M., and Kinet J.P. Identification of the low affinity receptor for immunoglobulin E on mouse mast cells and macrophages as FcγRII and FcγRII. J. Exp. Med. 176 (1992) 469-476
29. Watanabe T., Okano M., Hattori H., et al. Roles of FcgammaRIIB in nasal eosinophilia and IgE production in murine allergic rhinitis. Am. J. Respir Crit Care Med. 169 (2004) 105-112
30. Pawlik A., Carlsson L., Meisel P., et al. The FcRγIIa polymorphism in children with atopic diseases. Int. Arch. Allergy Immunol. 133 (2004) 233-238